Artivion Shipping Processes Disrupted by Ransomware AttackArtivion Shipping Processes Disrupted by Ransomware Attack

Artivion, a medtech company that manufactures and distributes products used in heart surgeries including mechanical human heart valves, implantable cardiac and vascular human tissues, stent grafts, and surgical sealants, on Monday disclosed a ransomware attack identified on Nov. 21 that continues to affect areas of operations.

The November attack reportedly forced the company to take some of its systems offline while initiating an investigation and engaging with legal, cybersecurity, and forensics advisors to assess, contain, and remediate the incident.

Artivion, which filed documents with the SEC on Monday, warned that the attack continues to have an impact on its operations including disruptions to some order and shipping processes, as well as to certain corporate operations, which the company said has been largely mitigated.

The attack, according to Artivion, “involved the acquisition and encryption of files. The company is working to securely restore its systems as quickly as possible and to evaluate any notification obligations.”

As of now, the incident has not had a “material impact on the company’s overall financial condition or results of operations and the incident is not reasonably likely to have a material impact on its financial conditions of results of operations,” according to the SEC filing.

Related:FastWave Granted 7th Utility Patent

While the company said that it “believes it has adequate insurance coverage,” cybersecurity insurance is not expected to cover some additional costs incurred.

Additionally, Artivion remains vulnerable to various risks due to the attack, like the impact of delays in restoration, and cannot provide assurances that the incident won’t have material impact in the future.

No known ransomware group has yet been named as the perpetrator of the attack nor has a group added Artivion to its leak site.